Examining protective factors for substance use problems and self-harm behavior during adolescence: A longitudinal co-twin control studyShow others and affiliations
2022 (English)In: Development and psychopathology (Print), ISSN 0954-5794, E-ISSN 1469-2198, Vol. 34, p. 1781-1802Article in journal (Refereed) Published
Abstract [en]
Sports participation, physical activity, and friendship quality are theorized to have protective effects on the developmental emergence of substance use and self-harm behavior in adolescence, but existing research has been mixed. This ambiguity could reflect, in part, the potential for confounding of observed associations by genetic and environmental factors, which previous research has been unable to rigorously rule out. We used data from the prospective, population-based Child and Adolescent Twin Study in Sweden (n = 18,234 born 1994-2001) and applied a co-twin control design to account for potential genetic and environmental confounding of sports participation, physical activity, and friendship quality (assessed at age 15) as presumed protective factors for adolescent substance use and self-harm behavior (assessed at age 18). While confidence intervals widened to include the null in numerous co-twin control analyses adjusting for childhood psychopathology, parent-reported sports participation and twin-reported positive friendship quality were associated with increased odds of alcohol problems and nicotine use. However, parent-reported sports participation, twin-reported physical activity, and twin-reported friendship quality were associated with decreased odds of self-harm behavior. The findings provide a more nuanced understanding of the risks and benefits of putative protective factors for risky behaviors that emerge during adolescence.
Place, publisher, year, edition, pages
Cambridge University Press, 2022. Vol. 34, p. 1781-1802
Keywords [en]
Adolescence, co-twin control, longitudinal, self-harm behavior, substance use
National Category
Public Health, Global Health and Social Medicine Psychiatry
Identifiers
URN: urn:nbn:se:oru:diva-100689DOI: 10.1017/S0954579422000724ISI: 000840544500001PubMedID: 35968852Scopus ID: 2-s2.0-85145171924OAI: oai:DiVA.org:oru-100689DiVA, id: diva2:1687736
Note
Funding agencies:
American Foundation for Suicide Prevention SRG-0-035-16
National Institute of Drug Abuse and Office of the Director: Office of Behavioral and Social Sciences Research DA042828
United States Department of Health & Human Services
National Institutes of Health (NIH) - USA
NIH National Institute on Drug Abuse (NIDA)
European Commission R00DA040727
Department of Health & Human Services
National Institutes of Health (NIH) - USA
NIH National Institute of Mental Health (NIMH) F31MH121039-01
2022-08-162022-08-162025-02-20Bibliographically approved